Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Cutaneous T-Cell Lymphoma 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Cutaneous T-Cell Lymphoma 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
BioCryst Pharmaceuticals, Inc. 33
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Kyowa Hakko Kirin Co., Ltd. 35
Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 35
Eisai Inc. 36
Clinical Trial Overview of Eisai Inc. 36
TopoTarget A/S 37
Clinical Trial Overview of TopoTarget A/S 37
Centocor Research and Development 38
Clinical Trial Overview of Centocor Research and Development 38
Minophagen Pharmaceutical Co., Ltd. 39
Clinical Trial Overview of Minophagen Pharmaceutical Co., Ltd. 39
TSD Japan, Inc. 40
Clinical Trial Overview of TSD Japan, Inc. 40
Transgene SA 41
Clinical Trial Overview of Transgene SA 41
Johnson & Johnson 42
Clinical Trial Overview of Johnson & Johnson 42
Allos Therapeutics, Inc. 43
Clinical Trial Overview of Allos Therapeutics, Inc. 43
Ligand Pharmaceuticals, Inc. 44
Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 44
Celgene Corporation 45
Clinical Trial Overview of Celgene Corporation 45
Cyclacel Pharmaceuticals Inc. 46
Clinical Trial Overview of Cyclacel Pharmaceuticals Inc. 46
Genmab A/S 47
Clinical Trial Overview of Genmab A/S 47
Therakos, Inc. 48
Clinical Trial Overview of Therakos, Inc. 48
Merck & Co., Inc. 49
Clinical Trial Overview of Merck & Co., Inc. 49
Eli Lilly and Company 50
Clinical Trial Overview of Eli Lilly and Company 50
Clinical Trial Overview of Top Universities / Institutes / Hospitals 51
Fred Hutchinson Cancer Research Center 51
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 51
Stanford University 52
Clinical Trial Overview of Stanford University 52
The University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 53
University of Alabama at Birmingham 54
Clinical Trial Overview of University of Alabama at Birmingham 54
University of Pittsburgh 55
Clinical Trial Overview of University of Pittsburgh 55
Robert H. Lurie Comprehensive Cancer Center of Northwestern University 56
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University 56
European Organization for Research and Treatment of Cancer 57
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 57
Memorial Sloan Kettering Cancer Center 58
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 58
Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS 59
Clinical Trial Overview of Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS 59
Mayo Clinic 60
Clinical Trial Overview of Mayo Clinic 60
University of Medicine and Dentistry New Jersey 61
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 61
Boston University 62
Clinical Trial Overview of Boston University 62
Fox Chase Cancer Center 63
Clinical Trial Overview of Fox Chase Cancer Center 63
UCLA's Jonsson Comprehensive Cancer Center 64
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 64
Dartmouth-Hitchcock Medical Center 65
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 65
FUDAN University 66
Clinical Trial Overview of FUDAN University 66
Simmons Cancer Center 67
Clinical Trial Overview of Simmons Cancer Center 67
Northwestern University 68
Clinical Trial Overview of Northwestern University 68
University of California, Los Angeles 69
Clinical Trial Overview of University of California, Los Angeles 69
Case Comprehensive Cancer Center 70
Clinical Trial Overview of Case Comprehensive Cancer Center 70
Five Key Clinical Profiles 71
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 101
List of Table
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical
Trials by Zone, 2012* 9
Cutaneous T-Cell Lymphoma Therapeutics Market,
Global, Clinical Trials by Top Countries, 2012* 10
Cutaneous T-Cell
Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top
Countries, 2012* 11
Cutaneous T-Cell Lymphoma Therapeutics Clinical
Trials, Asia-Pacific, Top Five Countries, 2012* 12
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
13
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, North
America, Top Countries, 2012* 14
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
15
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Central and
South America, Top Countries, 2012* 16
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Cutaneous
T-Cell Lymphoma Therapeutics Clinical Trials, G7 Countries, 2012* 18
Cutaneous T-Cell Lymphoma Therapeutics Market, G7 Countries, Clinical
Trials by Trial Status, 2012* 19
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials, E7 Countries, 2012* 20
Cutaneous T-Cell
Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial
Status, 2012* 21
Cutaneous T-Cell Lymphoma Therapeutics Market,
Global, Clinical Trials by Phase, 2012* 22
Cutaneous T-Cell Lymphoma
Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
23
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical
Trials by Trial Status, 2012* 24
Cutaneous T-Cell Lymphoma
Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Terminated
Clinical Trials, 2012* 26
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Key
Sponsors, 2012* 29
Cutaneous T-Cell Lymphoma Therapeutics Clinical
Trials, Global, Top Companies by Phase, 2012* 31
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent
Drugs, 2012* 32
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials
Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2012*
33
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market,
Global, Clinical Trials by Novartis AG, 2012* 34
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by
Kyowa Hakko Kirin Co., Ltd., 2012* 35
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc.,
2012* 36
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials
Market, Global, Clinical Trials by TopoTarget A/S, 2012* 37
Cutaneous
T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical
Trials by Centocor Research and Development, 2012* 38
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by
Minophagen Pharmaceutical Co., Ltd., 2012* 39
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by
TSD Japan, Inc., 2012* 40
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials Market, Global, Clinical Trials by Transgene SA, 2012*
41
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market,
Global, Clinical Trials by Johnson & Johnson, 2012* 42
Cutaneous
T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical
Trials by Allos Therapeutics, Inc., 2012* 43
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials Market, Global, Clinical Trials by Ligand
Pharmaceuticals, Inc., 2012* 44
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials Market, Global, Clinical Trials by Celgene Corporation,
2012* 45
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials
Market, Global, Clinical Trials by Cyclacel Pharmaceuticals Inc., 2012*
46
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market,
Global, Clinical Trials by Genmab A/S, 2012* 47
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by
Therakos, Inc., 2012* 48
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc.,
2012* 49
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials
Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 50
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global,
Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 51
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global,
Clinical Trials by Stanford University, 2012* 52
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by
The University of Texas M. D. Anderson Cancer Center, 2012* 53
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global,
Clinical Trials by University of Alabama at Birmingham, 2012* 54
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global,
Clinical Trials by University of Pittsburgh, 2012* 55
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by
Robert H. Lurie Comprehensive Cancer Center of Northwestern University,
2012* 56
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials
Market, Global, Clinical Trials by European Organization for Research and
Treatment of Cancer, 2012* 57
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering
Cancer Center, 2012* 58
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials Market, Global, Clinical Trials by Groupe Ouest Est d'Etude
des Leucemies et Autres Maladies du Sang GOELAMS, 2012* 59
Cutaneous
T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical
Trials by Mayo Clinic, 2012* 60
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials Market, Global, Clinical Trials by University of Medicine
and Dentistry New Jersey, 2012* 61
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston
University, 2012* 62
Cutaneous T-Cell Lymphoma Therapeutics Clinical
Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012*
63
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market,
Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center,
2012* 64
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials
Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center,
2012* 65
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials
Market, Global, Clinical Trials by FUDAN University, 2012* 66
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global,
Clinical Trials by Simmons Cancer Center, 2012* 67
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by
Northwestern University, 2012* 68
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials Market, Global, Clinical Trials by University
of California, Los Angeles, 2012* 69
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials Market, Global, Clinical Trials by Case
Comprehensive Cancer Center, 2012* 70
List of Chart
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical
Trials by Zone (%), 2012* 9
Cutaneous T-Cell Lymphoma Therapeutics
Market, Global, Clinical Trials by Top Countries, 2012* 10
Cutaneous
T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by
Top Countries, 2012* 11
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five
Countries (%), 2012* 13
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials, North America, Top Countries (%), 2012* 14
Cutaneous
T-Cell Lymphoma Therapeutics Clinical Trials, Central and South America,
Top Countries (%), 2012* 16
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials, BRIC Countries (%), 2012* 17
Cutaneous T-Cell
Lymphoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Cutaneous T-Cell Lymphoma Therapeutics Market, G7 Countries, Clinical
Trials by Trial Status, 2012* 19
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Cutaneous
T-Cell Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial
Status, 2012* 21
Cutaneous T-Cell Lymphoma Therapeutics Market,
Global, Clinical Trials by Phase (%), 2012* 22
Cutaneous T-Cell
Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase,
2012* 23
Cutaneous T-Cell Lymphoma Therapeutics Market, Global,
Clinical Trials by Trial Status, 2012* 24
Cutaneous T-Cell Lymphoma
Therapeutics Clinical Trials, Global, Average Enrollment Target Trends,
2005-2010 27
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials,
Global, Key Sponsors, 2012* 28
Cutaneous T-Cell Lymphoma Therapeutics
Clinical Trials, Global, Top Companies by Phase, 2012* 30
Cutaneous
T-Cell Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by
Prominent Drugs, 2012* 32
GlobalData Methodology 99